{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T19:48:31Z","timestamp":1779392911448,"version":"3.53.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T00:00:00Z","timestamp":1445299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1038\/bjc.2015.364","type":"journal-article","created":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T20:03:16Z","timestamp":1445371396000},"page":"1254-1258","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Impact of mutational status on survival in low-grade serous carcinoma of the ovary or peritoneum"],"prefix":"10.1038","volume":"113","author":[{"given":"David M","family":"Gershenson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte C","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwong-Kwok","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,20]]},"reference":[{"key":"BFbjc2015364_CR1","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1054\/bjoc.2001.1964","volume":"85","author":"HJ Andreyev","year":"2001","unstructured":"Andreyev HJ, Norman AR, Cunningham D, Oates J, Dix BR, Iacopetta BJ, Young J, Walsh T, Ward R, Hawkins N, Beranek M, Jandik P, Benamouzig R, Jullian E, Laurent-Puig P, Olschwang S, Muller O, Hoffmann I, Rabes HM, Zietz C, Troungos C, Valavanis C, Yuen ST, Ho JW, Croke CT, O'Donoghue DP, Giaretti W, Rapallo A, Russo A, Bazan V, Tanaka M, Omura K, Azuma T, Ohkusa T, Fujimori T, Ono Y, Pauly M, Faber C, Glaesener R, de Goeij AF, Arends JW, Andersen SN, L\u00f6vig T, Breivik J, Gaudernack G, Clausen OP, De Angelis PD, Meling GI, Rognum TO, Smith R, Goh HS, Font A, Rosell R, Sun XF, Zhang H, Benhattar J, Losi L, Lee JQ, Wang ST, Clarke PA, Bell S, Quirke P, Bubb VJ, Piris J, Cruickshank NR, Morton D, Fox JC, Al-Mulla F, Lees N, Hall CN, Snary D, Wilkinson K, Dillon D, Costa J, Pricolo VE, Finkelstein SD, Thebo JS, Senagore AJ, Halter SA, Wadler S, Malik S, Krtolica K, Urosevic N (2001) Kirsten ras mutations in patients with colorectal cancer: the \u2018RASCAL II\u2019 study. Br J Cancer 85: 692\u2013696.","journal-title":"Br J Cancer"},{"key":"BFbjc2015364_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc2772","volume":"10","author":"M Collado","year":"2010","unstructured":"Collado M, Serrano M (2010) Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 10: 51\u201357.","journal-title":"Nat Rev Cancer"},{"key":"BFbjc2015364_CR3","first-page":"3","volume":"99","author":"MA Crispens","year":"2002","unstructured":"Crispens MA, Bodurka D, Deavers M, Lu K, Silva EG, Gershenson DM (2002) Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential. Obstet Gynecol 99: 3\u201310.","journal-title":"Obstet Gynecol"},{"key":"BFbjc2015364_CR4","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ccr.2009.02.022","volume":"15","author":"N Dhomen","year":"2009","unstructured":"Dhomen N, Reis-Filho JS, da Rocha Dias S, Hayward R, Savage K, Delmas V, Larue L, Pritchard C, Marais R (2009) Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell 15: 294\u2013303.","journal-title":"Cancer Cell"},{"issue":"24","key":"BFbjc2015364_CR5","doi-asserted-by":"publisher","first-page":"6618","DOI":"10.1158\/1078-0432.CCR-14-1292","volume":"20","author":"C Emmanuel","year":"2014","unstructured":"Emmanuel C, Chiew Y-E, George J, Etemadmoghadam D, Sharma R, Russell P, Kennedy C, Fereday S, Hung J, Galletta L, Hogg R, Wain GV, Brand A, Balleine R, Anglesio MS, MacConaill LE, Palescandolo E, Hunter SM, Campbell I, Dobrovic A, Wong SQ, Do H, Clarke CL, Harnett PR, Bowtell DD, deFazio A Australian Ovarian Cancer Study (AOCS) (2014) Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS-pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver. Clin Cancer Res 20 (24): 6618\u20136630.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2015364_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S1470-2045(12)70572-7","volume":"14","author":"J Farley","year":"2013","unstructured":"Farley J, Brady WE, Vathipadiekal V, Lankes HA, Coleman R, Morgan MA, Mannel R, Yamada SD, Mutch D, Rodgers WH, Birrer M, Gershenson DM (2013) Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study. Lancet Oncol 14: 134\u2013140.","journal-title":"Lancet Oncol"},{"key":"BFbjc2015364_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/01.AOG.0000227787.24587.d1","volume":"108","author":"DM Gershenson","year":"2006","unstructured":"Gershenson DM, Sun CC, Lu KH, Coleman RL, Sood AK, Malpica A, Deavers MT, Silva EG, Bodurka DC (2006) Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary. Obstet Gynecol 108: 361\u2013368.","journal-title":"Obstet Gynecol"},{"key":"BFbjc2015364_CR8","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1200\/JCO.2015.61.0873","volume":"33","author":"DM Gershenson","year":"2015","unstructured":"Gershenson DM, Bodurka D, Lu K, Nathan LC, Milojevic L, Wong KK, Malpica A, Sun CC (2015) The impact of age and primary disease site on outcome of women with low-grade serous carcinoma of the ovary or peritoneum: Results of a large single-institution registry of a rare tumor. J Clin Oncol 33: 2675\u20132682.","journal-title":"J Clin Oncol"},{"key":"BFbjc2015364_CR9","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/cncr.27782","volume":"119","author":"RN Grisham","year":"2012","unstructured":"Grisham RN, Iyer G, Garg K, DeLair D, Hyman DM, Zhou Q, Iasonos A, Berger MF, Dao F, Spriggs DR, Levine DA, Aghajanian C, Solit DB (2012) BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer. Cancer 119: 548\u2013554.","journal-title":"Cancer"},{"key":"BFbjc2015364_CR10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/cncr.27730","volume":"119","author":"ML Johnson","year":"2012","unstructured":"Johnson ML, Sima CS, Chaft J, Paik PK, Pao W, Kris MG, Ladanyi M, Riely GJ (2012) Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas. Cancer 119: 356\u2013362.","journal-title":"Cancer"},{"key":"BFbjc2015364_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"BFbjc2015364_CR12","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/00000478-200404000-00009","volume":"28","author":"A Malpica","year":"2004","unstructured":"Malpica A, Deavers MT, Lu K, Bodurka DC, Atkinson EN, Gershenson DM, Silva EG (2004) Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol 28: 496\u2013504.","journal-title":"Am J Surg Pathol"},{"key":"BFbjc2015364_CR13","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.ygyno.2011.02.017","volume":"121","author":"KM Schmeler","year":"2011","unstructured":"Schmeler KM, Sun CC, Malpica A, Deavers MT, Bodurka DC, Gershenson DM (2011) Low-grade serous primary peritoneal carcinoma. Gynecol Oncol 121: 482\u2013486.","journal-title":"Gynecol Oncol"},{"key":"BFbjc2015364_CR14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ygyno.2007.01.030","volume":"105","author":"HS Shvartsman","year":"2007","unstructured":"Shvartsman HS, Sun CC, Bodurka DC, Mahajan V, Crispens M, Lu KH, Deavers MT, Malpica A, Silva EG, Gershenson DM (2007) Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma. Gynecol Oncol 105: 625\u2013629.","journal-title":"Gynecol Oncol"},{"key":"BFbjc2015364_CR15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/jnci\/95.6.484","volume":"95","author":"G Singer","year":"2003","unstructured":"Singer G, Oldt R, Cohen Y, Wang BG, Sidransky D, Kurman RJ, Shih I-M (2003) Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst 95: 484\u2013486.","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc2015364_CR16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/sj.bjc.6605164","volume":"101","author":"J Souglakos","year":"2009","unstructured":"Souglakos J, Philips J, Wang R, Marwah S, Silver M, Tzardi M, Silver J, Ogino S, Hooshmand S, Kwak E, Freed E, Meyerhardt JA, Saridaki Z, Georgoulias V, Finkelstein D, Fuchs CS, Kulke MH, Shivdasani RA (2009) Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer. Br J Cancer 101: 465\u2013472.","journal-title":"Br J Cancer"},{"key":"BFbjc2015364_CR17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/path.4252","volume":"231","author":"YT Tsang","year":"2013","unstructured":"Tsang YT, Deavers MT, Sun CC, Kwan S-Y, Kuo E, Malpica A, Mok SC, Gershenson DM, Wong K-K (2013) KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma. J Pathol 231: 449\u2013456.","journal-title":"J Pathol"},{"key":"BFbjc2015364_CR18","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1172\/JCI44165","volume":"120","author":"S Vicent","year":"2010","unstructured":"Vicent S, Chen R, Sayles LC, Lin C, Walker RG, Gillespie AK, Subramanian A, Hinkle G, Yang X, Saif S, Root DE, Huff V, Hahn WC, Sweet-Cordero EA (2010) Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models. J Clin Invest 120: 3940\u20133952.","journal-title":"J Clin Invest"},{"key":"BFbjc2015364_CR19","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2353\/ajpath.2010.100212","volume":"177","author":"K-K Wong","year":"2010","unstructured":"Wong K-K, Tsang YT, Deavers MT, Mok SC, Zu Z, Sun C, Malpica A, Wolf JK, Lu KH, Gershenson DM (2010) BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas. Am J Pathol 177: 1611\u20131617.","journal-title":"Am J Pathol"},{"key":"BFbjc2015364_CR20","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature05529","volume":"445","author":"W Xue","year":"2007","unstructured":"Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C, Lowe SW (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445: 656\u2013660.","journal-title":"Nature"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2015364.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2015364","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2015364.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:30:43Z","timestamp":1684416643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2015364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,20]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["BFbjc2015364"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2015.364","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,20]]},"assertion":[{"value":"29 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}